PMCPA Case
| Case | AUTH/1795/2/06 |
| Parties | General Practitioner v Merck Sharp & Dohme |
| Material | eMIMS email promoting an online presentation/edetail for Maxalt (rizatriptan) |
| Main issue | Most prominent “Maxalt” in banner not accompanied by non-proprietary name immediately adjacent |
| Third-party involvement | Agency and publications company distributed email; publications company added standard intro/banner without MSD’s knowledge |
| Applicable Code year | 2003 (case considered under 2006 Code; no difference for Clause 4.3) |
| Breach | Clause 4.3 |
| Sanction | Undertaking received |
| Complaint received | 05/06 February 2006 (reported as 6 February 2006 in the report) |
| Case completed | 05/06 March 2006 (reported as 6 March 2006 in the report) |
| Appeal | No appeal |
Download the full case report (PDF)
Reviewed by Dr Anzal Qurbain (FFPM) — ABPI Final Signatory
Got a question about this case?
Ask one of our 13 specialist ABPI advisors — instant answers, 24/7.
⭐ Business Intelligence Access
See the full compliance picture for every pharma company
291 Company Intelligence Reports — breach patterns, appeal history, industry ranking, PDF export.
One real case. One key lesson. Every week — free.